Cargando…
Reduction in oral corticosteroid use in patients receiving omalizumab for allergic asthma in the real-world setting
BACKGROUND: Oral corticosteroids (OCS) are commonly administered in patients with severe persistent allergic asthma. Despite their efficacy, they are associated with a wide variety of adverse events. The eXpeRience registry was set up to investigate real-world outcomes among patients receiving omali...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3879326/ https://www.ncbi.nlm.nih.gov/pubmed/24305549 http://dx.doi.org/10.1186/1710-1492-9-47 |